Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity

被引:351
作者
Shin, JY [1 ]
Fang, ZH [1 ]
Yu, ZX [1 ]
Wang, CE [1 ]
Li, SH [1 ]
Li, XJ [1 ]
机构
[1] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA
关键词
D O I
10.1083/jcb.200508072
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Huntington disease ( HD) is characterized by the preferential loss of striatal medium-sized spiny neurons ( MSNs) in the brain. Because MSNs receive abundant glutamatergic input, their vulnerability to excitotoxicity may be largely influenced by the capacity of glial cells to remove extracellular glutamate. However, little is known about the role of glia in HD neuropathology. Here, we report that mutant huntingtin accumulates in glial nuclei in HD brains and decreases the expression of glutamate transporters. As a result, mutant huntingtin (htt) reduces glutamate uptake in cultured astrocytes and HD mouse brains. In a neuron-glia coculture system, wild-type glial cells protected neurons against mutant htt-mediated neurotoxicity, whereas glial cells expressing mutant htt increased neuronal vulnerability. Mutant htt in cultured astrocytes decreased their protection of neurons against glutamate excitotoxicity. These findings suggest that decreased glutamate uptake caused by glial mutant htt may critically contribute to neuronal excitotoxicity in HD.
引用
收藏
页码:1001 / 1012
页数:12
相关论文
共 48 条
  • [1] BEAL MF, 1994, NEUROBIOL AGING, V15, P275
  • [2] Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation
    Behrens, P. F.
    Franz, P.
    Woodman, B.
    Lindenberg, K. S.
    Landwehrmeyer, G. B.
    [J]. BRAIN, 2002, 125 : 1908 - 1922
  • [3] Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: Implications for ischemia and Huntington's disease
    Calabresi, P
    Centonze, D
    Pisani, A
    Sancesario, G
    Gubellini, P
    Marfia, GA
    Bernardi, G
    [J]. ANNALS OF NEUROLOGY, 1998, 43 (05) : 586 - 597
  • [4] NMDA receptor function in mouse models of Huntington disease
    Cepeda, C
    Ariano, MA
    Calvert, CR
    Flores-Hernández, J
    Chandler, SH
    Leavitt, BR
    Hayden, MR
    Levine, MS
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2001, 66 (04) : 525 - 539
  • [5] Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice
    Clement, AM
    Nguyen, MD
    Roberts, EA
    Garcia, ML
    Boillée, S
    Rule, M
    McMahon, AP
    Doucette, W
    Siwek, D
    Ferrante, RJ
    Brown, RH
    Julien, JP
    Goldstein, LSB
    Cleveland, DW
    [J]. SCIENCE, 2003, 302 (5642) : 113 - 117
  • [6] LESION OF STRIATAL NEURONS WITH KAINIC ACID PROVIDES A MODEL FOR HUNTINGTONS-CHOREA
    COYLE, JT
    SCHWARCZ, R
    [J]. NATURE, 1976, 263 (5574) : 244 - 246
  • [7] Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
    Davies, SW
    Turmaine, M
    Cozens, BA
    DiFiglia, M
    Sharp, AH
    Ross, CA
    Scherzinger, E
    Wanker, EE
    Mangiarini, L
    Bates, GP
    [J]. CELL, 1997, 90 (03) : 537 - 548
  • [8] Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
    DiFiglia, M
    Sapp, E
    Chase, KO
    Davies, SW
    Bates, GP
    Vonsattel, JP
    Aronin, N
    [J]. SCIENCE, 1997, 277 (5334) : 1990 - 1993
  • [9] CELL-DAMAGE ASSOCIATED WITH CHANGING THE MEDIUM OF MESENCEPHALIC CULTURES IN SERUM-FREE MEDIUM IS MEDIATED VIA N-METHYL-D-ASPARTATE RECEPTORS
    DRISCOLL, BF
    LAW, MJ
    CRANE, AM
    [J]. JOURNAL OF NEUROCHEMISTRY, 1991, 56 (04) : 1201 - 1206
  • [10] Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease
    Dunah, AW
    Jeong, H
    Griffin, A
    Kim, YM
    Standaert, DG
    Hersch, SM
    Mouradian, MM
    Young, AB
    Tanese, N
    Krainc, D
    [J]. SCIENCE, 2002, 296 (5576) : 2238 - 2243